Miller Anestesia

235. Ginsberg MD, Busto R: Combating hyperthermia in

acute stroke: A significant clinical concern. Stroke

29:529–534, 1998.

236. Nussmeier NA: Management of temperature during

and after cardiac surgery. Tex Heart Inst J 32:472–

476, 2005.

237. Nussmeier NA, Cheng W, Marino M, et al: Tempe-

rature during cardiopulmonary bypass: The discre-

pancies between monitored sites. Anesth Analg

103:1373–1379, 2006.

238. Akata T, Setoguchi H, Shirozu K, et al: Reliability of

temperatures measured at standard monitoring

sites as an index of brain temperature during deep

hypothermic cardiopulmonary bypass conducted

for thoracic aortic reconstruction. J Thorac Cardio-

vasc Surg 133:1559–1565, 2007.

239. Johnson RI, Fox MA, Grayson A, et al: Should we

rely on nasopharyngeal temperature during cardio-

pulmonary bypass? Perfusion 17:145–151, 2002.

240. Nathan HJ, Parlea L, Dupuis JY, et al: Safety of deli-

berate intraoperative and postoperative hypother-

mia for patients undergoing coronary artery

surgery: A randomized trial. J Thorac Cardiovasc

Surg 127:1270–1275, 2004.

241. Nathan HJ, Wells GA, Munson JL, et al: Neuropro-

tective effect of mild hypothermia in patients

undergoing coronary artery surgery with cardio-

pulmonary bypass: A randomized trial. Circulation

104:I85–I91, 2001.

242. Insler SR, O’Connor MS, Leventhal MJ, et al: Asso-

ciation between postoperative hypothermia and

adverse outcome after coronary artery bypass

surgery. Ann Thorac Surg 70:175–181, 2000.

243. Frank SM, Fleisher LA, Breslow MJ, et al: Periope-

rative maintenance of normothermia reduces the

incidence of morbid cardiac events: A randomized

clinical trial. JAMA 277:1127–1134, 1997.

244. Thong WY, Strickler AG, Li S, et al: Hyperthermia

in the forty-eight hours after cardiopulmonary

bypass. Anesth Analg 95:1489–1495, 2002.

245. Grocott HP, Mackensen GB, Grigore AM, et al:

Postoperative hyperthermia is associated with cog-

nitive dysfunction after coronary artery bypass graft

surgery. Stroke 33:537–541, 2002.

246. Bar-Yosef S, Mathew JP, Newman MF, et al: Preven-

tion of cerebral hyperthermia during cardiac

surgery by limiting on-bypass rewarming in com-

bination with post-bypass body surface warming: A

feasibility study. Anesth Analg 99:641–646, 2004.

247. Rahn H: Body temperature and acid-base regula-

tion. Pneumonologie 151:87–94, 1974.

248. Murkin JM, Farrar JK, Tweed WA, et al: Cerebral

autoregulation and flow/metabolism coupling

during cardiopulmonary bypass: The influence of

Paco

. Anesth Analg 66:825–832, 1987.

249. Hickey PR, Hansen DD: Temperature and blood

gases: The clinical dilemma of acid-base manage-

ment for hypothermic cardiopulmonary bypass. In

Tinker JH (ed): Cardiopulmonary Bypass: Current

Concepts and Controversies. Philadelphia, WB

Saunders, 1989, pp 1–20.

250. Skaryak LA, Chai PJ, Kern FH, et al: Blood gas

management and degree of cooling: Effects on cere-

bral metabolism before and after circulatory arrest.

J Thorac Cardiovasc Surg 110:1649–1657, 1995.

251. Kurth CD, O’Rourke MM, O’Hara IB: Comparison

of pH-stat and alpha-stat cardiopulmonary bypass

on cerebral oxygenation and blood flow in relation

to hypothermic circulatory arrest in piglets. Anes-

thesiology 89:110–118, 1998.

252. Sakamoto T, Kurosawa H, Shin’oka T, et al: The

influence of pH strategy on cerebral and collateral

circulation during hypothermic cardiopulmonary

bypass in cyanotic patients with heart disease:

Results of a randomized trial and real-time moni-

toring. J Thorac Cardiovasc Surg 127:12–19, 2004.

253. Stephan H, Weyland A, Kazmaier S, et al: Acid-base

management during hypothermic cardiopulmo-

nary bypass does not affect cerebral metabolism but

does affect blood flow and neurological outcome. Br

J Anaesth 69:51–57, 1992.

254. Murkin JM, Martzke JS, Buchan AM, et al: A ran-

domized study of the influence of perfusion techni-

que and pH management strategy in 316 patients

undergoing coronary artery bypass surgery: I. Mor-

tality and cardiovascular morbidity. J Thorac Car-

diovasc Surg 110:340–348, 1995.

255. Patel RL, Turtle MR, Chambers DJ, et al: Alpha-stat

acid-base regulation during cardiopulmonary

bypass improves neuropsychologic outcome in

patients undergoing coronary artery bypass grafting.

J Thorac Cardiovasc Surg 111:1267–1279, 1996.

256. Shann KG, Likosky DS, Murkin JM, et al: An evi-

dence-based review of the practice of cardiopulmo-

nary bypass in adults: A focus on neurologic injury,

glycemic control, hemodilution, and the inflamma-

tory response. J Thorac Cardiovasc Surg 132:283–

290, 2006.

257. Bellinger DC, Wypij D, du Plessis AJ, et al: Develo-

pmental and neurologic effects of alpha-stat versus

pH-stat strategies for deep hypothermic cardiopul-

monary bypass in infants. J Thorac Cardiovasc Surg

121:374–383, 2001.

258. du Plessis AJ, Jonas RA, Wypij D, et al: Perioperative

effects of alpha-stat versus pH-stat strategies for deep

hypothermic cardiopulmonary bypass in infants. J

Thorac Cardiovasc Surg 114:991–1000, 1997.

259. Hindman BJ, Dexter F, Cutkomp J, et al: PH-stat

management reduces the cerebral metabolic rate for

oxygen during profound hypothermia (17 degrees

Celsius): A study during cardiopulmonary bypass in

rabbits. Anesthesiology 82:983–995, 1995.

260. Priestley MA, Golden JA, O’Hara IB, et al: Compa-

rison of neurologic outcome after deep hypother-

mic circulatory arrest with alpha-stat and pH-stat

cardiopulmonary bypass in newborn pigs. J Thorac

Cardiovasc Surg 121:336–343, 2001.

261. Hiramatsu T, Miura T, Forbess JM, et al: PH strate-

gies and cerebral energetics before and after circu-

latory arrest. JThorac Cardiovasc Surg 109:948–958,

1995.

262. Markowitz SD, Mendoza-Paredes A, Liu H, et al:

Response of brain oxygenation and metabolism to

deep hypothermic circulatory arrest in newborn

piglets: Comparison of pH-stat and alpha-stat stra-

tegies. Ann Thorac Surg 84:170–176, 2007.

263. Groom RC, Froebe S, Martin J, et al: Update on

pediatric perfusion practice in North America: 2005

survey. J Extra Corpor Technol 37:343–350, 2005.

264. Wan S, LeClerc JL, Vincent JL: Inflammatory res-

ponse to cardiopulmonary bypass: Mechanisms

involved and possible therapeutic strategies. Chest

112:676–692, 1997.

265. Nieman G, Searles B, Carney D, et al: Systemic infla-

mmation induced by cardiopulmonary bypass: A

review of pathogenesis and treatment. J Extra

Corpor Technol 31:202–210, 1999.

266. Schulze C, Conrad N, Schutz A, et al: Reduced

expression of systemic proinflammatory cytokines

after off-pump versus conventional coronary artery

bypass grafting. Thorac Cardiovasc Surg 48:364–

369, 2000.

267. Parolari A, Camera M, Alamanni F, et al: Systemic

inflammation after on-pump and off-pump coro-

nary bypass surgery: A one-month follow-up. Ann

Thorac Surg 84:823–828, 2007.

268. Searles B: Ultrafiltration techniques and CPB: What

we know and what we think we know. J Extra

Corpor Technol 38:64–65, 2006.

269. Tallman RD, Dumond M, Brown D: Inflammatory

mediator removal by zero-balance ultrafiltration

during cardiopulmonary bypass. Perfusion 17:111–

115, 2002.

270. Carrier M, Denault A, Lavoie J, et al: Randomized

controlled trial of pericardial blood processing with

a cell-saving device on neurologic markers in

elderly patients undergoing coronary artery bypass

graft surgery. Ann Thorac Surg 82:51–55, 2006.

271. Boldt J, Knothe C, Welters I, et al: Normothermic

versus hypothermic cardiopulmonary bypass: Do

changes in coagulation differ? Ann Thorac Surg

62:130–135, 1996.

272. Ohata T, Mitsuno M, Yamamura M, et al: Minimal

cardiopulmonary bypass attenuates neutrophil acti-

vation and cytokine release in coronary artery

bypass grafting. J Artif Organs 10:92–95, 2007.

273. Fromes Y, Gaillard D, Ponzio O, et al: Reduction of

the inflammatory response following coronary

bypass grafting with total minimal extracorporeal

circulation. Eur J Cardiothorac Surg 22:527–533,

2002.

274. el Habbal MH, Smith LJ, Elliott MJ, et al: Cardiopul-

monary bypass tubes and prime solutions stimulate

neutrophil adhesion molecules. Cardiovasc Res

33:209–215, 1997.

275. Rastan AJ, Eckenstein JI, Hentschel B, et al: Emer-

gency coronary artery bypass graft surgery for acute

coronary syndrome: Beating heart versus conven-

tional cardioplegic cardiac arrest strategies. Circu-

lation 114:I477–I485, 2006.

276. Leacche M, Carrier M, Bouchard D, et al: Improving

neurologic outcome in off-pump surgery: The “no

touch” technique. Heart Surg Forum 6:169–175,

2003.

277. Sedrakyan A, Wu AW, Parashar A, et al: Off-pump

surgery is associated with reduced occurrence of

stroke and other morbidity as compared with tradi-

tional coronary artery bypass grafting: A meta-

analysis of systematically reviewed trials. Stroke

37:2759–2769, 2006.

278. Ashraf S, Butler J, Tian Y, et al: Inflammatory media-

tors in adults undergoing cardiopulmonary bypass:

Comparison of centrifugal and roller pumps. Ann

Thorac Surg 65:480–484, 1998.

279. Baufreton C, Intrator L, Jansen PG, et al: Inflamma-

tory response to cardiopulmonary bypass using

roller or centrifugal pumps. Ann Thorac Surg

67:972–977, 1999.

280. de Vroege R, van Oeveren W, van Klarenbosch J, et

al: The impact of heparin-coated cardiopulmonary

bypass circuits on pulmonary function and the

release of inflammatory mediators. Anesth Analg

98:1586–1594, 2004.

281. Deptula J, Glogowski K, Merrigan K, et al: Evalua-

tion of biocompatible cardiopulmonary bypass

circuit use during pediatric open heart surgery. J

Extra Corpor Technol 38:22–26, 2006.

282. Ikuta T, Fujii H, Shibata T, et al: A new poly-2-me-

thoxyethylacrylate–coated cardiopulmonary bypass

circuit possesses superior platelet preservation and

inflammatory suppression efficacy. Ann Thorac

Surg 77:1678–1683, 2004.

283. Shimamoto A, Kanemitsu S, Fujinaga K, et al: Bio-

compatibility of silicone-coated oxygenator in car-

diopulmonarybypass.AnnThoracSurg69:115–120,

2000.

284. Alexiou C, Sheppard S, Tang A, et al: Leukocytes-

depleting filters preferentially remove activated

leukocytes and reduce the expression of surface

adhesion molecules during the simulated extracor-

poreal circulation of human blood. ASAIO J

52:438–444, 2006.

285. Chen YF, Tsai WC, Lin CC, et al: Leukocyte deple-

tion attenuates expression of neutrophil adhesion

molecules during cardiopulmonary bypass in

human beings. J Thorac Cardiovasc Surg 123:218–

224, 2002.

286. Chen YF, Tsai WC, Lin CC, et al: Effect of leukocyte

depletion on endothelial cell activation and tran-

sendothelial migration of leukocytes during cardio-

pulmonary bypass. Ann Thorac Surg 78:634–642,

2004.

287. Olivencia-Yurvati AH, Ferrara CA, Tierney N, et al:

Strategic leukocyte depletion reduces pulmonary

microvascular pressure and improves pulmonary

status post–cardiopulmonary bypass. Perfusion

18(Suppl 1)23–31, 2003.

288. Samankatiwat P, Samartzis I, Lertsithichai P, et al:

Leucocyte depletion in cardiopulmonary bypass: A

comparison of four strategies. Perfusion 18:95–105,

2003.

289. Mojcik CF, Levy JH: Aprotinin and the systemic

inflammatory response after cardiopulmonary

bypass. Ann Thorac Surg 71:745–754, 2001.

290. Goudeau JJ, Clermont G, Guillery O, et al: In high-

risk patients, combination of antiinflammatory pro-

cedures during cardiopulmonary bypass can reduce

incidences of inflammation and oxidative stress. J

Cardiovasc Pharmacol 49:39–45, 2007.

1736

Anestesia por subespecialidades en el adulto